These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 18096667)

  • 1. The regulation and function of the forkhead transcription factor, Forkhead box O1, is dependent on the progesterone receptor in endometrial carcinoma.
    Ward EC; Hoekstra AV; Blok LJ; Hanifi-Moghaddam P; Lurain JR; Singh DK; Buttin BM; Schink JC; Kim JJ
    Endocrinology; 2008 Apr; 149(4):1942-50. PubMed ID: 18096667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemosensitization of endometrial cancer cells through AKT inhibition involves FOXO1.
    Hoekstra AV; Ward EC; Hardt JL; Lurain JR; Singh DK; Buttin BM; Schink JC; Kim JJ
    Gynecol Oncol; 2008 Mar; 108(3):609-18. PubMed ID: 18234299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism and functional consequences of loss of FOXO1 expression in endometrioid endometrial cancer cells.
    Goto T; Takano M; Albergaria A; Briese J; Pomeranz KM; Cloke B; Fusi L; Feroze-Zaidi F; Maywald N; Sajin M; Dina RE; Ishihara O; Takeda S; Lam EW; Bamberger AM; Ghaem-Maghami S; Brosens JJ
    Oncogene; 2008 Jan; 27(1):9-19. PubMed ID: 17599040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased activation of the PI3K/AKT pathway compromises decidualization of stromal cells from endometriosis.
    Yin X; Pavone ME; Lu Z; Wei J; Kim JJ
    J Clin Endocrinol Metab; 2012 Jan; 97(1):E35-43. PubMed ID: 22072736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progesterone receptor-B induction of BIRC3 protects endometrial cancer cells from AP1-59-mediated apoptosis.
    Neubauer NL; Ward EC; Patel P; Lu Z; Lee I; Blok LJ; Hanifi-Moghaddam P; Schink J; Kim JJ
    Horm Cancer; 2011 Jun; 2(3):170-81. PubMed ID: 21760855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of apoptosis in endometrial cancer cells by psammaplysene A involves FOXO1.
    Berry E; Hardt JL; Clardy J; Lurain JR; Kim JJ
    Gynecol Oncol; 2009 Feb; 112(2):331-6. PubMed ID: 19041124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of SIRT1/FoxO1/SREBP-1 in the development of progestin resistance in endometrial cancer.
    Wang Y; Zhang L; Che X; Li W; Liu Z; Jiang J
    Arch Gynecol Obstet; 2018 Nov; 298(5):961-969. PubMed ID: 30206735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Akt regulates progesterone receptor B-dependent transcription and angiogenesis in endometrial cancer cells.
    Lee II; Maniar K; Lydon JP; Kim JJ
    Oncogene; 2016 Sep; 35(39):5191-201. PubMed ID: 26996671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The PRB-dependent FOXO1/IGFBP-1 axis is essential for progestin to inhibit endometrial epithelial growth.
    Nakamura M; Takakura M; Fujii R; Maida Y; Bono Y; Mizumoto Y; Zhang X; Kiyono T; Kyo S
    Cancer Lett; 2013 Aug; 336(1):68-75. PubMed ID: 23603247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional cross talk between the forkhead transcription factor forkhead box O1A and the progesterone receptor coordinates cell cycle regulation and differentiation in human endometrial stromal cells.
    Takano M; Lu Z; Goto T; Fusi L; Higham J; Francis J; Withey A; Hardt J; Cloke B; Stavropoulou AV; Ishihara O; Lam EW; Unterman TG; Brosens JJ; Kim JJ
    Mol Endocrinol; 2007 Oct; 21(10):2334-49. PubMed ID: 17609436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progesterone inhibition of Wnt/beta-catenin signaling in normal endometrium and endometrial cancer.
    Wang Y; Hanifi-Moghaddam P; Hanekamp EE; Kloosterboer HJ; Franken P; Veldscholte J; van Doorn HC; Ewing PC; Kim JJ; Grootegoed JA; Burger CW; Fodde R; Blok LJ
    Clin Cancer Res; 2009 Sep; 15(18):5784-93. PubMed ID: 19737954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Forkhead transcription factor FOXO1 is a direct target of progestin to inhibit endometrial epithelial cell growth.
    Kyo S; Sakaguchi J; Kiyono T; Shimizu Y; Maida Y; Mizumoto Y; Mori N; Nakamura M; Takakura M; Miyake K; Sakamoto M; Inoue M
    Clin Cancer Res; 2011 Feb; 17(3):525-37. PubMed ID: 21131554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of FOXO1 mRNA levels predicts treatment failure in patients with endometrial pathology conservatively managed with progestin-containing intrauterine devices.
    Reyes HD; Carlson MJ; Devor EJ; Zhang Y; Thiel KW; Samuelson MI; McDonald M; Yang S; Stephan JM; Savage EC; Dai D; Goodheart MJ; Leslie KK
    Gynecol Oncol; 2016 Jan; 140(1):152-60. PubMed ID: 26524723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of AKT with the orally active allosteric AKT inhibitor, MK-2206, sensitizes endometrial cancer cells to progestin.
    Pant A; Lee II; Lu Z; Rueda BR; Schink J; Kim JJ
    PLoS One; 2012; 7(7):e41593. PubMed ID: 22911820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progesterone receptors induce FOXO1-dependent senescence in ovarian cancer cells.
    Diep CH; Charles NJ; Gilks CB; Kalloger SE; Argenta PA; Lange CA
    Cell Cycle; 2013 May; 12(9):1433-49. PubMed ID: 23574718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin inhibits estrogen-dependent endometrial cancer cell growth by activating the AMPK-FOXO1 signal pathway.
    Zou J; Hong L; Luo C; Li Z; Zhu Y; Huang T; Zhang Y; Yuan H; Hu Y; Wen T; Zhuang W; Cai B; Zhang X; Huang J; Cheng J
    Cancer Sci; 2016 Dec; 107(12):1806-1817. PubMed ID: 27636742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [MiR-135b promotes proliferation of endometrial carcinoma cells by targeting FOXO1].
    Yue Z; Shen JJ; Huang QT; Qin YF; Li XN; Liu GB
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 May; 36(5):675-80. PubMed ID: 27222184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibiting the PI3K/Akt pathway reversed progestin resistance in endometrial cancer.
    Gu C; Zhang Z; Yu Y; Liu Y; Zhao F; Yin L; Feng Y; Chen X
    Cancer Sci; 2011 Mar; 102(3):557-64. PubMed ID: 21205080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active FOXO1 Is a Key Determinant of Isoform-Specific Progesterone Receptor Transactivation and Senescence Programming.
    Diep CH; Knutson TP; Lange CA
    Mol Cancer Res; 2016 Feb; 14(2):141-62. PubMed ID: 26577046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PI3K Pathway Effectors pAKT and FOXO1 as Novel Markers of Endometrioid Intraepithelial Neoplasia.
    Strickland AL; Rivera G; Lucas E; John G; Cuevas I; Castrillon DH
    Int J Gynecol Pathol; 2019 Nov; 38(6):503-513. PubMed ID: 30256235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.